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Introduction
Recognition of the need to regulate research on human beings can be traced back 
to reactions against the abuses associated with German and Japanese research dur-
ing World War II. However, as the twentieth century rolled out it was increasingly 
recognized that a number of abuses, in terms of research on human subjects, contin-
ued into the post-war period in both democratic and Eastern Bloc countries (Mason 
and McCall Smith 2010). Revelations during the Nuremburg Trials, for example, 
of the atrocities committed in the name of medical experimentation during World 
War II, combined with other twentieth-century medical research scandals such as 
the Tuskegee Syphilis Study 1932–72 (Adams 1996), the Willowbrook hepatitis stud-
ies (Krugman 1986) and the New Zealand cervical cancer inquiry (Cartwright 1988; 
Paterson 2010) has helped develop widespread resolve regarding the need to protect 
participants in human research projects and to continue to monitor the conduct of 
such research internationally. The first internationally accepted set of ethical guide-
lines with regard to these issues was the Nuremburg Code published in 1947 (for fur-
ther comment see Annas and Grodin 1992). The World Medical Association (WMA) 
publicly endorsed the principles expressed in the Nuremburg Code by drawing up 
the Declaration of Helsinki in 1964 (WMA 1964). This declaration has been revised a 
number of times since its first publication.
The past 30 years have seen a number of countries and organizations highlight 
issues surrounding the ethics of research on human subjects: for example the Bel-
mont Principles (National Commission 1979) and the Irish Council for Bioethics 
(2004). In the nursing arena, the International Council of Nurses (ICN 1996), An Bord 
Altranais (the Irish Nursing Board) (2007), the Royal College of Nursing (RCN 2009) 
and the Northern Nurses’ Federation (1995) all published new or revised guidelines 
for nursing research. Issues regarding the human rights of research participants have 
also been underlined by the Council of Europe (Council of Europe 1997).
Guided by such international instruments as the Nuremberg Code (1947), 
the United Nations Declaration on Human Rights (United Nations 1948), especially 
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articles 1, 3, 5, 12 and 19, the United Nations Convention on the Rights of the 
Child (1989), the Belmont Report (National Commission 1979), and the Declaration 
of Helsinki (WMA 2008), in addition to various ethical theories that have become 
influential in health care ethics in general, such as Kantian ethics and the principle- 
based framework of Beauchamp and Childress (2001), a conceptualization of appro-
priate ways to treat and protect human beings, both fully functioning adults and 
vulnerable human beings such as children, older people, the terminally ill, has 
emerged and continues to be modified over time. 
However, as we move into the middle of the second decade of the twenty-first 
century there are certain ethical principles that are seen as fundamental to the frame-
work of ethics that guides decisions regarding the morally appropriate considera-
tion and treatment of human beings during research activities. For example the Irish 
Council of Bioethics in 2004 commented as follows:
Research involving human participants should be based on a fundamental 
moral commitment to the individuals concerned and to advancing human 
welfare, knowledge and understanding. A number of guiding moral princi-
ples govern the ethical review of research proposals. These principles aim to 
protect the well-being and rights of research participants/volunteers. 
(Irish Council for Bioethics 2004: 6)
Some important considerations
Human beings are deserving of respect and protection as inalienable rights (United 
Nations 1948). This is equally the case during research activities as it is in any other 
circumstances. Based on the work of the philosopher Immanuel Kant, such values 
are expressed in the principle of respect for persons, sometimes translated as respect 
for autonomy. Such expressions, of course, raise questions of the definition of per-
son and autonomy, and of when and in what set of circumstances such concepts are 
and are not applicable. However, for the purposes of this chapter we will take it that 
respect is applicable to all human participants in health care research. The question 
then arises regarding what this actually means in the case of individual participants 
in a particular research project. At a minimum, the considerations explored below 
are relevant.
Respect for the human person
In the context of research activity the principle of respect for persons is frequently 
articulated in terms of rights – both rights to autonomous participation and welfare 
rights – that is, the right to have one’s support and protection needs respected. Some 
such rights are the following: 
•	 the	right	not	to	be	injured	or	mistreated
•	 the	right	to	give	informed,	un-coerced	consent	to	participate	in	the	particu-
lar piece of research
•	 the	right	to	privacy,	confidentiality	and/or	anonymity.
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In terms of protecting the participant’s right not to be injured or mistreated, it is nor-
mally the duty of the research team not to expose the research participant to signifi-
cantly burdensome, unreasonable, known or predictable risk. On occasion, however, 
when significant burden or predictable material risk is unavoidable, it is the duty 
of the research team to provide appropriate information on the likely burden and/
or risk involved, so that the participant can determine if they fully understand and 
accept that burden or risk. Thus, for example, in drug trials and trials involving medi-
cal devices, the trials are phased and normally commence with non-human (labora-
tory and animal) trials. Such measures help to provide insight into likely effects of the 
particular drug or device – at least on non-human subjects. Thus, by the time clinical 
trials (trials using human participants) commence, previous phases give insight into 
the actions of the agent (drug or device, for example). This provides a certain level 
of confidence that the agent will either not cause significant physical risk to the trial 
participants or that any such risks, which will be explained to the participant prior to 
participation, can and will be managed and/or mitigated by the research team. Where 
discomfort, burden and/or risk cannot be avoided, it must be proportionate to the 
anticipated gain, either directly to the individual participant and/or to humanity or 
society. Such considerations are directly linked to the discussion of the principles of 
beneficence and non-maleficence below.
Informed consent
Respect for the individual’s right to make decisions about themselves and their life 
(respect for autonomy) requires that research participants are adequately and prop-
erly informed regarding the nature of the research project. For example, potential 
participants must be informed with regards to what will be required of the individual 
participant, including the approximate time requirement, any procedures that will be 
performed on him or her, any known or predictable risks or side effects, the nature 
of the trial (where a clinical trial is part of the research design), whether a placebo is 
being used, whether the trial is blinded and so forth. Such information enables the 
potential research participant to give informed consent to participate in the par-
ticular research activity or project. 
There are two other crucial elements that must be in play to ensure that consent 
is not only informed but also voluntary – and thus autonomously exercised. These 
elements are:
•	 The	 participant	must	 have	 the	 capacity	 to	 both	 understand	 the	 informa-
tion being provided regarding the particular piece of research, including the 
implications of participation for the individual, and the (cognitive) ability to 
exercise consent. 
•	 The	participant	must	be	 free	 from	coercion.	Thus	 the	participant	must	be	
assured and accept, for example, that refusal to consent will not affect her/
his current care and treatment if the individual is being cared for by any 
member of a health care team, either in hospital or in the community. The 
individual should also be free from any other form of duress related to the 
research in question – from the research or health care team or from relatives 
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or significant others (see Doyal and Tobias (2001) for a detailed discussion of 
the principal requirements of informed consent).
In instances where the potential research participant is a patient, practitioners should 
be aware of the profound influence that they may have on patients to whom they 
suggest participating in research. For example Kass et al. (1996: 4), in a study on par-
ticipant consent to involvement in cancer clinical trials, express it thus:
Clinicians should be mindful of the tremendous influence they have over 
their patients, given that the mere suggestion of enrolment in research by a 
patient’s personal physician was interpreted by many patients to be endorse-
ment.
Some research, in the context of health and developing the appropriate evidence base 
for health care provision, will require the participation of individuals who are incom-
petent or temporarily not competent to give consent to participate in the research 
activity. Such people should only be involved in research under very clearly articu-
lated and strictly monitored conditions. If it is impossible to carry out the particular 
research project with competent participants (or, for example, to wait for the uncon-
scious person to regain consciousness, or where this would invalidate the study), con-
sent must be sought from the legally authorized guardian of the individual involved. 
As a general rule of thumb, incompetent individuals or members of other vulnerable 
groups should only be involved in research when it is reasonable to expect that the 
individual, or the group of which she/he is a member, will ultimately benefit from the 
research in question, and where the potential participant is exposed to minimal risk 
and burden. This is part of protecting the welfare of such individuals.
Should the potential participant, identified as incompetent to consent, be able to 
give assent to participation in research, such assent should be sought – in addition to 
the consent of the legal guardian as described above. In such circumstances a decision 
to withhold assent should be acknowledged and respected; thus this individual will 
not be included in the research project in question. 
A corollary of informed consent is that the individual should be assured that 
her/his participation, responses, tissue samples and so forth are being used for the 
purposes of the identified research project only. Personal information and/or donated 
material, such as tissue samples, will then be destroyed under properly regulated 
mechanisms that are fully protective of the autonomy and privacy of the participant. 
If this is not the case, the potential participant should be made aware, explicitly, that 
it is intended to use the material for another, future study or studies. This enables the 
potential participant to knowingly consent, or withhold consent, to any potential 
future study. It clearly protects against a recurrence of cases, such as those reported 
over the past decade in both Ireland and the UK (The Royal Liverpool Children’s 
Inquiry Report 2001; The Dunne Inquiry 2005; Government of Ireland 2006), where 
human organs were retained, post mortem, for potential use in current or future 
research projects.
In some, perhaps many, health research projects, private, intimate information 
may be sought from the research participant during data collection: for example, 
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information on previous medical history, information on personal behaviours and 
habits or information on the participant’s children, siblings and so forth. Intimate, 
personally significant information may also be discovered as a result of interventions 
designed into the particular research initiative – i.e. genetic screening, chromosome 
studies, screening for risk of cancer and cardiac disease, alcohol use, sexual activity, 
patient satisfaction surveys and so forth. Research participants, in order to be prop-
erly protected from unwarranted risk of this personal information becoming available 
publicly, and thus potentially being used to the detriment of the research participant, 
(and to enable the participant to feel safe to participate in the particular study) should 
be assured that such personal information will be kept private and confiden-
tial. Where strict confidentiality cannot be assured, appropriate mechanisms should 
be designed into the study to protect participants. Participants can thus be assured 
that their identity will not be divulged – the data-collection, handling and stor-
age processes protect anonymity. In this latter case, for example, participants 
are normally not asked to divulge their names on self-completed questionnaires – 
such as when completing patient satisfaction questionnaires or when a staff member 
completes a staff survey.
Beneficence and non-maleficence
Two of the internationally accepted, fundamental core principles underpinning 
both health care practice and research are the principle of beneficence (do 
good) and the mirror principle of non-maleficence (do not harm). Thus one 
should do good to and should not harm one’s patients, clients or research partici-
pants. Clearly some interventions (for diagnostic, therapeutic and/or research pur-
poses) may be uncomfortable, burdensome or painful. Some may cause a degree of 
harm – for example surgical intervention. However, the basic stance is that the core 
function of the health care professional is to work for the benefit of the patient or 
client from a health perspective. Thus the practitioner or the researcher must not 
cause unnecessary or avoidable harm or distress to their patients, clients or research 
participants. Article 6 of the Declaration of Helsinki states this position with par-
ticular clarity: ‘In medical research involving human subjects, the well-being 
of the individual research subject must take precedence over all other interests’ 
(WMA 2008).
To continue to develop the evidence base for health care practice, relevant, well-
designed research is both important and essential. Conversely, the results of poorly 
designed research may, at worst, seriously harm participants or, at best, waste their 
time, while at the same time making misleading or detrimental contributions to the 
evidence base. This means that significant time and effort should be invested into 
research training and research oversight and governance. 
At the level of the individual participant, the duty to do good, and prevent harm, 
warrants equal vigilance. In instances where the participant is likely to experience 
discomfort, burden and/or risk, it must be proportionate to the expected gain from 
the research study – either directly to the participant and/or to society as a whole. In 
the context of clinical trials, particularly drug trials for example, this gives rise to a 
number of issues. In the first instance, in order to warrant the use of a clinical trial 
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there must be genuine doubt with regards to the efficacy of the drug or treatment 
intervention being considered. This is often referred to as a state of equipoise. Such 
conditions exist when either the evidence is not available from which to make a 
judgement regarding the impact of a particular intervention, or in situations where 
the evidence that does exist is inconclusive and/or contradictory. (For a useful discus-
sion of this concept in particular, and ethical issues underlying intervention studies 
in general, see O’Mathúna 2012.)
As indicated above, when moving to set up clinical trials the relevant ground-
work must be completed and verified before introducing human trials. Appropriate 
oversight of the trial, including close monitoring of participant responses, must be 
assured (see Chapter 6 for an outline and discussion of research governance). Fur-
thermore, when patients are participating in experimental drug trials they must be 
fully aware of this, including being made aware of the very high chance of the experi-
mental intervention not ‘working’. From the perspective of the ethical conduct of 
the clinical trial it is good ethical practice for the research team to have a protocol in 
place to help determine when participation in the trial should be terminated. Such 
a protocol is particularly pertinent in experimental trials of new anti-cancer agents. 
The lack of such a protocol can lead to unnecessary hardship for very ill, vulnerable 
patients and for the staff who care for them. (For a detailed description and discus-
sion of these and related issues see Hobson 2003.)
A corollary of the principles of beneficence and non-maleficence, in terms of 
clinical trials, is that a study must be stopped immediately when the risks are found to 
outweigh the potential benefits. A similar imperative exists when there is conclusive 
evidence of positive and beneficial results from one of the agents under investigation.
Justice
In the context of research activity the principle of justice can be conceptualized as 
fairness (Rawls 1985). In Rawlsian terms, fairness is achieved if the principles guid-
ing distribution of capabilities and resources, for example, are applied so as to ensure 
that the ‘least advantaged’ are benefited and not harmed or forgotten. Thus research 
participants should be treated fairly. For example, if participants are being put at 
considerable discomfort, inconvenience or risk (given the discussion of the ethi-
cal principles providing an appropriate framework for ethically acceptable research 
activity it is assumed that participants are fully aware of the demands being made of 
them), then it may be completely reasonable to compensate a participant for such 
inconvenience and any expenses they may incur due to their participation in the 
particular research project. However, that compensation should not be such as to 
induce financially vulnerable individuals to place themselves at significant risk for 
financial gain. 
Another issue that emerges during discussion of the principle of justice, in the 
context of research activity, is who should participate in research activity? Should 
certain groups be excluded on grounds such as vulnerability? Over the past number 
of years it has been recognized that all patient/client groups, including those identi-
fied as especially vulnerable, have the right to participate in – indeed may be neces-
sary participants in – investigations to improve health care and to generate a sound 
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evidence base for such care. For example the fifth article of the Declaration of Hel-
sinki (WMA 2008) stated the following:
Medical progress is based on research that ultimately must include studies 
involving human subjects. Populations that are under-represented in medical 
research should be provided appropriate access to participation in research.
However, article 17 qualifies this in the following manner:
Medical research involving a disadvantaged or vulnerable population or 
community is only justified if the research is responsive to the health needs 
and priorities of this population or community and if there is a reasonable 
likelihood that this population or community stands to benefit from the 
results of the research.
Groups that come to mind are children, the terminally ill, those who are physically 
disabled or cognitively impaired. It is a matter of justice that such individuals are 
enabled to participate in relevant research as fully as possible. Such participation 
assists in developing our understanding of the health and illness experience of cer-
tain vulnerable groups. It helps gain insight into their perceptions of, responses to, 
and requirements of, interventions provided by health care practitioners (and the 
health service they encounter) over the course of their lives or their illness trajectory.
However, special considerations need to come into play to ensure appropriate 
support and protection of such individuals. In particular, specific mechanisms must 
be put in place to ensure that the welfare rights of vulnerable groups are recognized 
and protected. For detailed discussion of research with vulnerable groups please see 
Chapter 7.
Working it through: ethical issues and the stages of the 
research process
As indicated above, ethical issues and considerations permeate the entire research 
process. This begins with the research questions that are asked (and that receive 
research grant funding – as against those questions which do not get asked and those 
projects which, through lack of funding, do not proceed) and continues right through 
to reporting of research findings and terminating the researcher/respondent contact. 
Researchers need to be sensitive to the nature of particular research agendas and 
the motivations, personal, political, institutional and sociocultural, that drive them. 
For example, the current drivers of evidence-based practice in health care are at least 
tripartite – political, economic and professional. As practitioners we are becoming 
more convinced that our practice must be evidence-based – and there are numerous 
clinical studies going on attempting to develop our evidence base. However, it is 
interesting to note that we are a lot less clear on what we mean by evidence, or what 
should count as evidence in health care practice (Scott 2006). 
It seems reasonably clear that answers to the latter question are crucial in inform-
ing the former question. Despite this, little work is currently being carried out, or 
being funded, in relation to questions regarding the nature of the evidence base 
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appropriate for health care and nursing practice. This problem has philosophical, 
moral and professional implications. One of the most serious is the potential impact 
that our lack of knowledge and understanding regarding the nature of an appropriate 
evidence base will have on patient care. 
However, once the researcher has decided on the appropriate research question 
(see Chapter 3), it is a moral and professional requirement to ensure that the selected 
piece of research is necessary. Thus the researcher needs to be sure that the knowl-
edge is required, and does not already exist in a sufficiently comprehensive state. 
This indicates the need for the researcher to be equipped to do the required literature 
searching. To do otherwise is likely to lead not only to a poorly refined research ques-
tion and consequent poor research design; it is also wasteful of resources and shows 
a lack of respect for the study respondents and those who provide support for the 
researcher.
Assuming that the research question is a legitimate and useful one, the researcher 
must draw on personal or outside expertise in designing an appropriate study that 
will provide a real possibility of gaining answers to the research question posed, or 
which will provide a firm basis for further work. This is not only a methodological 
issue. Sound study design is required in order to ensure that the study is ethically 
sound. Lack of appropriate expertise in study design is again, at a minimum, waste-
ful of time and other resources and indicates a lack of respect for respondents and 
those supporting the work of the researcher. At worst, such a lack of expertise may be 
positively damaging to the research respondents. Given that health care researchers 
frequently carry out research with respondents already made vulnerable through ill-
ness, this is particularly unacceptable practice from an ethical perspective. 
Once the researcher is confident that the design of the study is appropriate and 
that the data-collection methods or tools will obtain the data required, ethical con-
siderations, we would argue, again concern notions of respect, with a focus on the 
following issues:
•	 The	role	of	the	practitioner/researcher	and	the	implications	of	the	researcher	
identifying him or herself as a nurse, doctor, physiotherapist, clinical psy-
chologist and so forth. The implications are potentially both positive and 
negative. Such self-identification may make recruitment to a study much 
easier. However, it may also confuse or set up false expectations in patient 
participants. Conflicts of interest are likely to arise where a practitioner is 
using his/her own patient group in research. Such confusion of roles should 
normally be avoided. Where a self-identified, qualified practitioner is carry-
ing out a piece of research (for postgraduate work, for example), it should 
be made clear to participants that the researcher is not responsible for the 
participants’ care and that refusal to participate in the research will not have 
any impact on care provision. This should also be expressed clearly on either 
the written information participants receive regarding the research study 
and/or on the consent form.
•	 The	balance	of	potential	inconvenience	or	risk	to	participants	over	potential	
benefit to participants and/or others.
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•	 Appropriate	and	sufficient	information	should	be	given	regarding	the	nature	
of the study to enable the potential participant to make an informed choice, 
and to give or withhold informed, voluntary consent. In instances where 
the participants are unable to receive the information or to make informed 
decisions, for whatever reason, clear transparent processes which aim to 
ascertain and protect participants’ interests, throughout the period of their 
participation, must be instituted. The continued right of competent partici-
pants to withdraw from the study, without any negative consequences to 
the participant, must be made clear at the commencement of the study and 
thereafter, as the study unfolds, as required.
•	 Issues	 of	 anonymity	 and	 confidentiality	must	 be	 given	 careful	 considera-
tion, and detailed information on these notions given to participants. As de 
Raeve (1996: 114) points out, this may be particularly pertinent for health 
practitioner/researchers who may, for example, be used to the rather broader 
notion of confidentiality which is used in the health care team. 
In empirical studies, data collection is a crucial area for research ethics. Ethical issues 




•	 guaranteeing	 appropriate	 ethical	 behaviour	 from	 researchers	 during	 the	
data-collection period.
As discussed above, in obtaining permission from individual participants, the 
issue of informed consent is central. It should be noted that normally practition-
ers directly involved in care giving do not obtain participants’ consent to par-
ticipate in research as clear conflict of interest issues may arise. However, clinical 
nurses in particular may have a significant role in supporting patient participants 
in making informed decisions regarding participation in a particular piece of 
research (see, for example, Pranulis 1997; Watts 1997; Sadler et al. 1999; An Bord 
Altranais 2007). 
In line with the principle of respect for persons, participants’ anonymity, con-
fidentiality and willingness to participate must be ensured. Risks, benefits and bur-
dens to respondents must be explored. The risk or burden to the participant must be 
weighed against the potential benefits of the research findings to the general popu-
lation or specific patient populations. Participants in clinical trials must be as fully 
informed as possible regarding the nature and objectives of the trial. It should be 
made clear to the participants the nature of any specific risks or benefits that may 
accrue to trial participants. It is also important to bear in mind that informed consent 
is an ongoing process. Research participants may have questions that arise during the 
data-collection process in particular that should be addressed. Participants must also 
be informed and assured that they may withdraw their consent and cease participa-
tion at any point during the research process, without this negatively impacting on 
them or their care.
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Ethics and data analysis
Analysis of data is an interesting issue from an ethical perspective. At a minimum, the 
researcher and/or his or her research advisers need to have a good grasp of both the 
strengths and limitations of the method of analysis or any analytical tools used. This 
is important from an ethical perspective to ensure that no inappropriate claims are 
made, based on the analysis. The relevance of this point in terms of clinical practice 
and patient care is clear. A significant reason for carrying out empirical research in 
health care is to improve patient care and develop sound policy and practices. Inap-
propriate analysis is likely to lead to inaccurate results and thus potentially to poor 
policy and practice.
Ethics and the relationship with research participants
De Raeve (1996: 115) highlights the lack of attention to ethical issues surrounding 
‘leaving the field’ or termination of the relationship between researcher and partici-
pant. This is likely to be a particularly complex issue for researchers involved in some 
forms of qualitative research and in some psychosocially focused intervention trials. 
The researcher needs to be aware of the potential problems in this type of researcher–
participant relationship. Steps should be taken to ensure that the participant does 
not confuse the research relationship with a therapeutic, counselling-type relation-
ship or a friendship. Insight and personal integrity is actively required from the 
researcher throughout the data-collection period to guard against misuse or abuse of 
the researcher–participant relationship. (See O’Mathúna 2012 for a wide-ranging and 
helpful analysis of the importance of researcher integrity throughout the research 
process.)
Ethics and dissemination of research
From an ethics perspective, if the researcher is to value and respect the contribu-
tions made by participants, funding bodies and others supportive of the research 
effort, it is incumbent on the researcher to report and disseminate the findings of the 
particular study – positive and negative – in the most effective ways available to the 
researcher. 
In reporting the study results, the ethical issues include continued protection of 
the rights of, and honouring promises made to, participants (for example, confiden-
tiality, protection of privacy, anonymity), reporting findings truthfully, accurately 
and completely, citing appropriately the work of others and ensuring the authorship 
credits and acknowledgements are stated accurately. To do otherwise once again indi-
cates lack of respect for the various actors in the research process. It is also wasteful 
of valuable resources, including those of future researchers who might have gained 
from the signposting of ‘blind alleys’ and from insights into the findings, strengths 
and weaknesses of the unreported study.
Conclusion
A number of the key ethical principles relevant to research with human participants 
are explored in this chapter. The ethical understanding thus gained is then applied 
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to the component elements of the research process. High-quality, ethically sound 
research is important in developing the evidence base for health care practice and in 
the provision of effective, humane patient care. Understanding the principles guiding 
ethically sound research activity is thus a key component in evidence-based health 
care delivery. 
Key concepts
 • Respect for persons: in the context of research, this refers to ensuring, for example, 
that participants are adequately informed about the research project. Such informa-
tion should enable participants to give informed consent to participate in the piece of 
research in question. Respect for persons also requires that participants are assured of 
confidentiality or anonymity and that their privacy is protected. 
 • Beneficence and non-maleficence: literally this means, respectively, do good and do 
no harm. in the research context, participants should be adequately protected and 
researchers should avoid exposing participants to unnecessary and undue discomfort, 
burden or risk. 
 • Justice: research participants should be treated fairly. All sectors of the population 
including, where relevant, vulnerable groups and individuals, should be enabled to 
participate in research initiatives. Such participation may require additional protections 
to be in place. 
 • Ethical issues permeate the entire research process, from question identification and 
selection to dissemination of findings.
Key readings
 • T.l. Beauchamp and J.F. Childress, Principles of Biomedical Ethics, 5th edn (new York: 
oxford University Press, 2001)
This is a classical text in health care ethics. The authors are the originators of what has 
become known as the Georgetown principles: respect for autonomy, beneficence, non-
maleficence and justice. There are many interesting case applications of the principles, 
including research-relevant cases.
 • J.K. Mason and R.A. McCall Smith, Law and Medical Ethics, 8th edn (london: 
Butterworth, 2010)
This text provides a detailed discussion of ethical principles relevant to the health care con-
text including the health research context.
 • d.P. o’Mathúna, Ethical considerations in designing intervention studies, in B. Mazurek 
Melnyk and d. Morrison-Beedy (eds) Intervention Research: Designing, Conducting, Ana-
lyzing, and Funding: A Practical Guide for Success (new York: Springer Publishing, 2012), 
pp. 75–89
O’Mathúna’s chapter provides a comprehensive discussion of the research ethics issues 
involved in the design and implementation of intervention studies. The chapter includes a 
very useful discussion of the issue of researcher integrity.
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